https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10646837/

AllNews Books Images Maps Videos Shopping

Anti-GM-CSF otilimab versus sarilumab or placebo in patients ...

Sep 11, 2023 · Objectives. To investigate the efficacy and safety of otilimab, an anti-granulocyte-macrophage colony-stimulating factor antibody, ...

Fifteen-year trajectories of multimorbidity and polypharmacy in ...

www.ncbi.nlm.nih.gov › PMC8880753

After stratifying for age, sex and multimorbidity at baseline, our aim is to analyse time trends in incident multimorbidity and polypharmacy in the 15-year ...

Missing: PMC10646837/ | Show results with:PMC10646837/

Fetuin‐A, inter‐α‐trypsin inhibitor, glutamic acid and ChoE (18:0) are ...

www.ncbi.nlm.nih.gov › PMC8787095

Jan 24, 2022 · Dear Editor,. The mechanistic pathways leading to immune dysregulation and complications driven by uncontrolled severe acute respiratory ...

Missing: PMC10646837/ | Show results with:PMC10646837/

Anti-GM-CSF otilimab versus sarilumab or placebo in patients ... - Stork

www.storkapp.me › pubpaper

Anti-GM-CSF otilimab versus sarilumab or placebo in patients with rheumatoid arthritis and inadequate response to targeted therapies: a phase III randomised ...

The efficacy and safety of targeting GM-CSF in arthritis. - Europe PMC

europepmc.org › article › med

... article for free, from open access legal sources, via Unpaywall: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7541049 Unpaywall. Citations & impact. Impact ...

Modularly Programmable Nanoparticle Vaccine Based on ...

www.ncbi.nlm.nih.gov › PMC7927624

Jan 6, 2021 · Here, modularly programmed, polyethyleneimine (PEI)‐based NP vaccines are reported for simple production of personalized cancer vaccines.

Missing: PMC10646837/ | Show results with:PMC10646837/

Deficits in neuronal architecture but not over-inhibition are main ... - NCBI

www.ncbi.nlm.nih.gov › PMC10793573

Nov 23, 2023 · In this study, we investigated the impact of Dual specificity tyrosine-phosphorylation-regulated kinase 1A (Dyrk1A) overexpression, ...

Missing: PMC10646837/ | Show results with:PMC10646837/

JAK inhibition as a therapeutic strategy for immune ... - Europe PMC

europepmc.org › article › med

This corrects "JAK inhibition as a therapeutic strategy for immune and inflammatory diseases." Nat Rev Drug Discov. 2017 Dec;16(12 ):843-862. Share this article ...

Microenvironmental stiffness mediates cytoskeleton re-organization in ...

www.ncbi.nlm.nih.gov › PMC8917190

Mar 11, 2022 · In the current study, by using substrates with different stiffnesses fabricated by silicon-based elastomer polydimethylsiloxane (PDMS), we ...

Missing: PMC10646837/ | Show results with:PMC10646837/

T cell receptor excision circles are potential predictors of survival in ...

www.ncbi.nlm.nih.gov › PMC9540498

Sep 20, 2022 · This single-center retrospective study aimed to evaluate T cell receptor excision circles (TREC) and kappa-deleting recombination excision ...

Missing: PMC10646837/ | Show results with:PMC10646837/